Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Sponsor: Weill Medical College of Cornell University
Listed as NCT02316314, this observational or N/A phase trial focuses on Friedreich's Ataxia and remains actively recruiting participants. Sponsored by Weill Medical College of Cornell University, it has been updated 20 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
20 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Oct 2024 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 15 earlier versions
-
Sep 2023 — Dec 2023 [monthly]
Recruiting
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Oct 2019 — Oct 2020 [monthly]
Active Not Recruiting
-
Oct 2018 — Oct 2019 [monthly]
Active Not Recruiting
-
Jul 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .